Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C8H11N2O3.Na |
| Molecular Weight | 206.1743 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC(=O)\C=C(/C)N[C@@H]1CO[N-]C1=O
InChI
InChIKey=RNZYSARTHBLHQB-OGFXRTJISA-M
InChI=1S/C8H12N2O3.Na/c1-5(3-6(2)11)9-7-4-13-10-8(7)12;/h3,7H,4H2,1-2H3,(H2,9,10,11,12);/q;+1/p-1/t7-;/m1./s1
Pentizidone is a prodrug which is hydrolyzed spontaneously and converted to D-cycloserine. Merck selected pentizidone as a companion product for D-fluoroalanine with the anticipation that it would be better tolerated than cycloserine itself. The expectation was that D-fluoroalanine and pentizidone would be synergistic in killing bacteria. The combination of the two enzyme inhibitors proved to have potent antibiotic activity in animal studies and abolished the self-reversal phenomenon. D-cycloserine acts on D-alanyl-D-alanine synthetase.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Simultaneous quantification of cycloserine and its prodrug acetylacetonylcycloserine in plasma and urine by high-performance liquid chromatography using ultraviolet absorbance and fluorescence after post-column derivatization. | 1987-02-20 |
|
| In vitro activity of fludalanine combined with pentizidone compared with those of other agents. | 1984-05 |
|
| Experimental pneumonia due to Haemophilus influenzae: observations on pathogenesis and treatment. | 1984-05 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
259-759-3
Created by
admin on Mon Mar 31 18:12:58 GMT 2025 , Edited by admin on Mon Mar 31 18:12:58 GMT 2025
|
PRIMARY | |||
|
55694-87-6
Created by
admin on Mon Mar 31 18:12:58 GMT 2025 , Edited by admin on Mon Mar 31 18:12:58 GMT 2025
|
PRIMARY | |||
|
VSM253T8YI
Created by
admin on Mon Mar 31 18:12:58 GMT 2025 , Edited by admin on Mon Mar 31 18:12:58 GMT 2025
|
PRIMARY | |||
|
DTXSID50971059
Created by
admin on Mon Mar 31 18:12:58 GMT 2025 , Edited by admin on Mon Mar 31 18:12:58 GMT 2025
|
PRIMARY | |||
|
300000055584
Created by
admin on Mon Mar 31 18:12:58 GMT 2025 , Edited by admin on Mon Mar 31 18:12:58 GMT 2025
|
PRIMARY | |||
|
23684615
Created by
admin on Mon Mar 31 18:12:58 GMT 2025 , Edited by admin on Mon Mar 31 18:12:58 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
